Published in J Cancer Res Clin Oncol on January 01, 1988
NMR structure of a complex between MDM2 and a small molecule inhibitor. J Biomol NMR (2004) 0.91
[N,N'-Bis(salicylidene)-1,2-phenylenediamine]metal complexes with cell death promoting properties. J Biol Inorg Chem (2009) 0.85
Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol Cell Biol (1983) 11.06
Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res (1984) 6.56
Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. Cell (2000) 5.08
The structure of cell adhesion molecule uvomorulin. Insights into the molecular mechanism of Ca2+-dependent cell adhesion. EMBO J (1987) 4.00
Hippocampal and entorhinal cortex high-frequency oscillations (100--500 Hz) in human epileptic brain and in kainic acid--treated rats with chronic seizures. Epilepsia (1999) 3.96
High-frequency oscillations in human brain. Hippocampus (1999) 3.89
Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet (2001) 3.88
A new crystal structure, Ca2+ dependence and mutational analysis reveal molecular details of E-cadherin homoassociation. EMBO J (1999) 3.20
Structure and function of laminin: anatomy of a multidomain glycoprotein. FASEB J (1990) 3.16
Shapes, domain organizations and flexibility of laminin and fibronectin, two multifunctional proteins of the extracellular matrix. J Mol Biol (1981) 3.15
Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia (2001) 2.90
The crystal structure of a five-stranded coiled coil in COMP: a prototype ion channel? Science (1996) 2.87
A new nomenclature for the laminins. Matrix Biol (1994) 2.82
alpha 1D (Cav1.3) subunits can form l-type Ca2+ channels activating at negative voltages. J Biol Chem (2001) 2.77
Kinetics of the cooperative association of actin to actin filaments. Biophys Chem (1975) 2.55
Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing. Infect Immun (1995) 2.48
Protease resistance and conformation of laminin. Eur J Biochem (1982) 2.47
Cerebral microdialysis combined with single-neuron and electroencephalographic recording in neurosurgical patients. Technical note. J Neurosurg (1999) 2.46
Electron-microscopical approach to a structural model of intima collagen. Biochem J (1983) 2.32
Chronic epileptogenesis requires development of a network of pathologically interconnected neuron clusters: a hypothesis. Epilepsia (2000) 2.31
CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer (2008) 2.23
Conformational changes of the recombinant extracellular domain of E-cadherin upon calcium binding. Eur J Biochem (1994) 2.23
Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J (1991) 2.23
Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins. J Biol Chem (1994) 2.22
7-S collagen: characterization of an unusual basement membrane structure. Eur J Biochem (1980) 2.19
Changes in blood lymphocyte populations after multiple trauma: association with posttraumatic complications. Crit Care Med (1999) 2.18
Laminin-nidogen complex. Extraction with chelating agents and structural characterization. Eur J Biochem (1987) 2.15
Foreign body ingestion: review and suggested guidelines for management. Endoscopy (1987) 2.08
BBID: the biological biochemical image database. Bioinformatics (2000) 2.07
Homophilic adhesion of E-cadherin occurs by a co-operative two-step interaction of N-terminal domains. EMBO J (1996) 2.05
Miltefosine for new world cutaneous leishmaniasis. Clin Infect Dis (2004) 2.02
Prognosis and treatment of disseminated uveal melanoma. Cancer (1993) 1.98
Single amino acid substitutions in one Ca2+ binding site of uvomorulin abolish the adhesive function. Cell (1990) 1.98
Folding mechanism of the triple helix in type-III collagen and type-III pN-collagen. Role of disulfide bridges and peptide bond isomerization. Eur J Biochem (1980) 1.96
Stabilization of short collagen-like triple helices by protein engineering. J Mol Biol (2001) 1.88
A health-related quality of life instrument for patients evaluated for epilepsy surgery. Med Care (1992) 1.84
Electrophysiologic analysis of a chronic seizure model after unilateral hippocampal KA injection. Epilepsia (1999) 1.83
Treatment of Bolivian mucosal leishmaniasis with miltefosine. Clin Infect Dis (2006) 1.82
Outcome assessment for epilepsy surgery: the impact of measuring health-related quality of life. Ann Neurol (1995) 1.82
MspA provides the main hydrophilic pathway through the cell wall of Mycobacterium smegmatis. Mol Microbiol (2001) 1.79
Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3. Ann Neurol (1980) 1.78
Structure and interactions of heparan sulfate proteoglycans from a mouse tumor basement membrane. Eur J Biochem (1984) 1.77
Domains of laminin with growth-factor activity. Cell (1989) 1.75
Acquiring simultaneous EEG and functional MRI. Clin Neurophysiol (2000) 1.75
Subunit structure and assembly of the globular domain of basement-membrane collagen type IV. Eur J Biochem (1984) 1.74
Comparative localization of epileptic foci in partial epilepsy by PCT and EEG. Ann Neurol (1982) 1.73
Diet restriction in rhesus monkeys lowers fasting and glucose-stimulated glucoregulatory end points. Am J Physiol (1995) 1.72
Three-dimensional preoperative maps of hippocampal atrophy predict surgical outcomes in temporal lobe epilepsy. Neurology (2005) 1.69
Evidence for coiled-coil alpha-helical regions in the long arm of laminin. EMBO J (1985) 1.68
Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer. Ann Oncol (2002) 1.68
Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP) Ann Oncol (1997) 1.63
D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. Epilepsy Res (1996) 1.61
[The effect of needle type and immobilization on postspinal headache]. Anaesthesist (1997) 1.59
Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution. Ann Hematol (2004) 1.59
FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy. Neurology (2008) 1.59
Localization of flexible sites in thread-like molecules from electron micrographs. Comparison of interstitial, basement membrane and intima collagens. J Mol Biol (1984) 1.59
Bendamustine hydrochloride activity against doxorubicin-resistant human breast carcinoma cell lines. Anticancer Drugs (1996) 1.56
Macromolecular organization of natural and recombinant lung surfactant protein SP 28-36. Structural homology with the complement factor C1q. J Mol Biol (1988) 1.55
An autonomous folding unit mediates the assembly of two-stranded coiled coils. Proc Natl Acad Sci U S A (1998) 1.54
Calcium binding and homoassociation of E-cadherin domains. Biochemistry (1997) 1.54
Exchange of ADP, ATP and 1: N6-ethenoadenosine 5'-triphosphate at G-actin. Equilibrium and kinetics. Eur J Biochem (1979) 1.53
A substitution of cysteine for glycine 748 of the alpha 1 chain produces a kink at this site in the procollagen I molecule and an altered N-proteinase cleavage site over 225 nm away. J Biol Chem (1988) 1.51
Irinotecan in the treatment of colorectal cancer: clinical overview. J Clin Oncol (2001) 1.50
Electron microscopy and other physical methods for the characterization of extracellular matrix components: laminin, fibronectin, collagen IV, collagen VI, and proteoglycans. Methods Enzymol (1987) 1.48
Finally, a randomized, controlled trial of epilepsy surgery. N Engl J Med (2001) 1.47
Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors. J Clin Oncol (1997) 1.46
Crystal structure of a naturally occurring parallel right-handed coiled coil tetramer. Nat Struct Biol (2000) 1.46
Homophilic adhesion by cadherins. Curr Opin Struct Biol (1999) 1.46
Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy. Ann Neurol (1982) 1.43
Magnetic resonance imaging in intractable partial epilepsy: correlative studies. Ann Neurol (1986) 1.43
Characterization of the Chlamydia trachomatis vacuole and its interaction with the host endocytic pathway in HeLa cells. Infect Immun (1997) 1.42
Extended and globular protein domains in cartilage proteoglycans. Biochem J (1987) 1.42
Novel tumor suppressor locus in human chromosome region 3p14.2. J Natl Cancer Inst (1999) 1.42
Energy transfer between fluorescent proteins using a co-expression system in Mycobacterium smegmatis. Gene (2001) 1.42
Pooled safety analysis of BAY 43-9006 (sorafenib) monotherapy in patients with advanced solid tumours: Is rash associated with treatment outcome? Eur J Cancer (2006) 1.42
Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent. Clin Infect Dis (2001) 1.41
Generic substitutions for antiepileptic drugs. Neurology (1990) 1.41
[Anesthesia in carotid surgery]. Anasthesiol Intensivmed Notfallmed Schmerzther (1994) 1.40
Chemotherapy of human colon cancer xenografts in athymic nude mice. Cancer (1977) 1.39
Structure of recombinant N-terminal globule of type VI collagen alpha 3 chain and its binding to heparin and hyaluronan. EMBO J (1992) 1.38
Role of the frontal lobes in the propagation of mesial temporal lobe seizures. Epilepsia (1992) 1.38
Increased glucose metabolism during long-duration recurrent inhibition of hippocampal pyramidal cells. J Neurosci (1984) 1.38
D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity. Cancer Res (2001) 1.38
Electron microscopy of native cartilage oligomeric matrix protein purified from the Swarm rat chondrosarcoma reveals a five-armed structure. J Biol Chem (1992) 1.38
Development of miltefosine as an oral treatment for leishmaniasis. Trans R Soc Trop Med Hyg (2006) 1.37
Three conformationally distinct domains in the amino-terminal segment of type III procollagen and its rapid triple helix leads to and comes from coil transition. Eur J Biochem (1978) 1.37
Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Oncol (1995) 1.36
Cartilage proteoglycans. Assembly with hyaluronate and link protein as studied by electron microscopy. Biochem J (1988) 1.34
Electrophysiological correlates of pathology and surgical results in temporal lobe epilepsy. Brain (1975) 1.34
Interictal metabolic anatomy of mesial temporal lobe epilepsy. Arch Neurol (1993) 1.33
The extracellular matrix of Volvox carteri: molecular structure of the cellular compartment. J Cell Biol (1989) 1.33
Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside. Leukemia (1994) 1.32
Interictal cerebral glucose metabolism in partial epilepsy and its relation to EEG changes. Ann Neurol (1982) 1.32
Risk factors for venous thromboembolic events in cancer patients. Ann Oncol (2005) 1.32
Domain structure of cartilage proteoglycans revealed by rotary shadowing of intact and fragmented molecules. Biochem J (1984) 1.29
Communication, quality of life and age: results of a 5-year prospective study in breast cancer patients. Ann Oncol (2003) 1.29